These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12462127)

  • 1. Histidine kinase-mediated signal transduction systems of pathogenic microorganisms as targets for therapeutic intervention.
    Stephenson K; Hoch JA
    Curr Drug Targets Infect Disord; 2002 Sep; 2(3):235-46. PubMed ID: 12462127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence- and antibiotic resistance-associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy.
    Stephenson K; Hoch JA
    Pharmacol Ther; 2002; 93(2-3):293-305. PubMed ID: 12191621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms.
    Stephenson K; Hoch JA
    Curr Med Chem; 2004 Mar; 11(6):765-73. PubMed ID: 15032730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two-component signal transduction as attractive drug targets in pathogenic bacteria].
    Utsumi R; Igarashi M
    Yakugaku Zasshi; 2012; 132(1):51-8. PubMed ID: 22214580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y; Eguchi Y; Watanabe T; Okamoto S; Doi A; Utsumi R
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histidine kinases as targets for new antimicrobial agents.
    Matsushita M; Janda KD
    Bioorg Med Chem; 2002 Apr; 10(4):855-67. PubMed ID: 11836091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-component and phosphorelay signal-transduction systems as therapeutic targets.
    Stephenson K; Hoch JA
    Curr Opin Pharmacol; 2002 Oct; 2(5):507-12. PubMed ID: 12324251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors targeting two-component signal transduction.
    Watanabe T; Okada A; Gotoh Y; Utsumi R
    Adv Exp Med Biol; 2008; 631():229-36. PubMed ID: 18792693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Shoot the Messenger: PASTA Kinases as Virulence Determinants and Antibiotic Targets.
    Pensinger DA; Schaenzer AJ; Sauer JD
    Trends Microbiol; 2018 Jan; 26(1):56-69. PubMed ID: 28734616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.
    Worthington RJ; Blackledge MS; Melander C
    Future Med Chem; 2013 Jul; 5(11):1265-84. PubMed ID: 23859207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial signal transduction networks via connectors and development of the inhibitors as alternative antibiotics.
    Utsumi R
    Biosci Biotechnol Biochem; 2017 Sep; 81(9):1663-1669. PubMed ID: 28743208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system.
    Dubrac S; Msadek T
    Adv Exp Med Biol; 2008; 631():214-28. PubMed ID: 18792692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-component phosphorelays in fungal mitochondria and beyond.
    Chauhan N
    Mitochondrion; 2015 May; 22():60-5. PubMed ID: 25858273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview.
    Tiwari S; Jamal SB; Hassan SS; Carvalho PVSD; Almeida S; Barh D; Ghosh P; Silva A; Castro TLP; Azevedo V
    Front Microbiol; 2017; 8():1878. PubMed ID: 29067003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae.
    Lange R; Wagner C; de Saizieu A; Flint N; Molnos J; Stieger M; Caspers P; Kamber M; Keck W; Amrein KE
    Gene; 1999 Sep; 237(1):223-34. PubMed ID: 10524254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
    Boibessot T; Zschiedrich CP; Lebeau A; Bénimèlis D; Dunyach-Rémy C; Lavigne JP; Szurmant H; Benfodda Z; Meffre P
    J Med Chem; 2016 Oct; 59(19):8830-8847. PubMed ID: 27575438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class III Histidine Kinases: a Recently Accessorized Kinase Domain in Putative Modulators of Type IV Pilus-Based Motility.
    Adebali O; Petukh MG; Reznik AO; Tishkov AV; Upadhyay AA; Zhulin IB
    J Bacteriol; 2017 Sep; 199(18):. PubMed ID: 28484044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General Aspects of Two-Component Regulatory Circuits in Bacteria: Domains, Signals and Roles.
    Padilla-Vaca F; Mondragón-Jaimes V; Franco B
    Curr Protein Pept Sci; 2017; 18(10):990-1004. PubMed ID: 27514854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of inhibitors of bacterial two-component signal transduction systems.
    Stephenson K; Yamaguchi Y; Hoch JA
    J Biol Chem; 2000 Dec; 275(49):38900-4. PubMed ID: 10978341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.